DOI: https://doi.org/10.36347/sjmcr.2026.v14i03.011

Pages: 363-366

Endoscopic sleeve gastroplasty (ESG) is a promising minimally invasive option in the management of obesity, allowing a significant reduction in gastric volume while avoiding the risks associated with bariatric surgery. We report the case of a morbidly obese patient who underwent ESG using the OverStitch Apollo endoscopic suturing system, after a comprehensive multidisciplinary pre therapeutic assessment and no anesthetic, metabolic or psychiatric contraindication. The procedure, performed under general anesthesia, was completed without incident or early complication, with an estimated 70% reduction in gastric volume and a weight loss of 20 kg at 6 month follow up. ESG appears to be an effective and safe alternative for selected patients with obesity, and its integration into structured care pathways could help improve weight and metabolic control.